Gastrointestinal Oncology Program

Gastrointestinal Oncology Program - View Full PDF

HOSPITAL

University Hospitals Seidman Cancer Center

KEY CONTACTS

Amitabh Chak, MD, Gastroenterology
(216-844-3217), Amitabh.Chak@UHhospitals.org

Jennifer Dorth, MD, Discipline Lead, Radiation Oncology
(216-286-3903), Jennifer.Dorth@UHhospitals.org

Jennifer Eads, MD, Upper GI Disease Team Leader, Medical Oncology
(216-844-6003), Jennifer.Eads@UHhospitals.org

Jeffrey Hardacre, MD, Discipline Lead, Surgical Oncology
(cell 216-965-4945), Jeffrey.Hardacre@UHhospitals.org

Smitha Krishnamurthi, MD, Lower GI Disease Team Leader, Medical Oncology
(216-844-1006), Smitha.Krishnamurthi@UHhospitals.org

Richard Lee, MD, Integrative Oncology, Palliative Care,Hepatocellular Cancer
(216-844-5884), Richard.Lee@UHhospitals.org

Philip Linden, MD, Esophageal Surgery
(cell 216-392-5282), Philip.Linden@UHhospitals.org

APPOINTMENT LINE

Please call Jeanie Wyckhouse, New Patient Access Coordinator,
at 216-844-5020 or email Jeanie.Wyckhouse@UHhospitals.org.

For hospital transfers, please call 216-844-1111.

Conditions Treated

  • Esophagogastric cancers, including Barrett’s esophagus
  • Biliary cancers
  • Pancreatic cancers: pancreatic adenocarcinoma, pancreatic cystic neoplasms,pancreatic neuroendocrine tumors and rare pancreatic tumors
  • Small intestinal cancers
  • Colorectal cancers
  • Anal cancers
  • Gastrointestinal stromal tumors
  • Neuroendocrine cancers

Procedures and Therapies

  • Endoscopic ultrasound, endoscopic mucosal resection and endoscopic submucosal dissection for the staging and treatment of early esophageal cancers
  • Noninvasive treatments (stenting, robotic and laparoscopic procedures, transanal resections)
  • Liver-directed therapies, including resection of metastases, surgical ablation, transarterial chemoembolization, radioembolization and percutaneous microwave ablation
  • Colo-anal reconstruction/sphincter-sparing surgery
  • Enhanced recovery programs following colorectal surgery
  • Radiation therapy, including proton beam therapy, IMRT and MR planning, and intraoperative radiation
  • Chemotherapy and immunotherapy, including clinical trials

Distinguishing Features

  • Part of NCI-designated Case Comprehensive Cancer Center
  • Multidisciplinary consultation and disease-specific tumor boards
  • First in Northeast Ohio to perform minimally invasive esophagectomy
  • Lowest esophagectomy mortality rate in the nation
  • One of three NCI Barrett’s Esophagus Translational Research Network centers, via Case Western Reserve University
  • Innovative clinical trials of new treatments
  • One of six National Cancer Institute Specialized Programs of Research Excellence (SPORE) centers for gastrointestinal cancers in the U.S., via Case Western Reserve University
  • National leadership in clinical pathway development
  • Noninvasive diagnostic technology using new imaging methodologies
  • Only Proton Therapy Center in Ohio
  • Genetic analysis of tumors to guide personalized therapy
  • Genetic risk assessment to guide preventive strategies in cancer-prone families
  • Supportive and Integrative Oncology program
  • Specialized Adolescent and Young Adult (AYA) cancer program


About UH Cleveland Medical Center
At the core of University Hospitals’ $4 billion health system is UH Cleveland Medical Center, ranked among America’s best hospitals by U.S. News & World Report. UH Cleveland Medical Center is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women’s health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main campus includes UH Rainbow Babies & Children’s Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women’s Hospital, Ohio’s only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University.